Reports for TEVA-IRBESARTAN HCTZ
Brand name
TEVA-IRBESARTAN HCTZ
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02330539 |
Ingredients
IRBESARTAN HYDROCHLOROTHIAZIDE |
Ingredient Strength
300 MG 25 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-IRBESARTAN HCTZ | 100 | Actual shortage | 2024-04-11 | 2024-04-18 | 224898 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2023-11-03 | 2024-03-07 | 209122 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2021-06-10 | 2021-09-10 | 140681 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2021-03-11 | 2021-05-06 | 135555 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2020-09-22 | 2021-03-04 | 124743 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2020-07-14 | 2020-07-15 | 120235 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2020-04-10 | 2021-03-04 | 111865 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2019-10-24 | 2019-11-28 | 97153 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2017-08-01 | 2017-09-19 | 17839 |
Showing 1 to 9 of 9
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0